Zobrazeno 1 - 10
of 10 810
pro vyhledávání: '"long‐COVID"'
Autor:
Warren Szewczyk, Annette L. Fitzpatrick, Herve Fossou, Nicole L. Gentile, Nona Sotoodehnia, Surabhi B. Vora, T. Eoin West, Jeanne Bertolli, Jennifer R. Cope, Jin-Mann S. Lin, Elizabeth R. Unger, Quan M. Vu
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Recovery from SARS CoV-2 infection is expected within 3 months. Long COVID occurs after SARS-CoV-2 when symptoms are present for more than 3 months that are continuous, relapsing and remitting, or progressive. Better understanding
Externí odkaz:
https://doaj.org/article/e2410f2f32fb467a8917026d2e78a65c
Autor:
J. C. Berentschot, L. M. Bek, M. H. Heijenbrok-Kal, J. van Bommel, G. M. Ribbers, J. G. J. V. Aerts, M. E. Hellemons, H. J. G. van den Berg-Emons, The CO-FLOW collaboration Group
Publikováno v:
Journal of Intensive Care, Vol 12, Iss 1, Pp 1-19 (2024)
Abstract Background Many patients hospitalized for COVID-19 experience long-term health problems, but comprehensive longitudinal data up to 2 years remain limited. We aimed to (1) assess 2-year trajectories of health outcomes, including comparison be
Externí odkaz:
https://doaj.org/article/c3f3302cf14e4095891f164aad58d9bc
Autor:
Dana Yelin, Nassem Ghantous, Muhammad Awwad, Vered Daitch, Talya Kalfon, Michal Mor, Shira Buchrits, Yair Shafir, Irit Shapira-Lichter, Leonard Leibovici, Dafna Yahav, Ili Margalit, Dorit Shitenberg
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-6 (2024)
Abstract Impaired pulmonary diffusing capacity for carbon monoxide (DLCO) following COVID-19 has been consistently reported among individuals recovering from severe-critical infection. However, most long COVID cases follow non-severe COVID-19. We ass
Externí odkaz:
https://doaj.org/article/e36fe4b821db4cf99655b498fda6fff6
Autor:
Ignacio Pérez Catalán, Celia Roig Martí, Sofía Folgado Escudero, Ana Segura Fábrega, María Varea Villanueva, Sergio Fabra Juana, Elena Domínguez Bajo, Germán Herrero Rodríguez, María José Esteve Gimeno, Daniela Palomo de la Sota, Alejandro Cardenal Álvarez, María Lidón Mateu Campos, Jorge Usó Blasco, Jose Manuel Ramos Rincón
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract The long-term effects of SARS-CoV-2 infection, and their determinants, are still unknown. This study aimed to assess symptoms one year after admission for COVID-19, according to the organ/system involved, and to identify factors. Cross-secti
Externí odkaz:
https://doaj.org/article/3b79b015ae104d48ac23f2231b2bef83
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-17 (2024)
Abstract Background: The Stroop task was used to investigate differences in cognitive function between Long COVID (LC), Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) and healthy control subjects. Methods: Subjects viewed four color wo
Externí odkaz:
https://doaj.org/article/628059e96e2c4ccf93c177ec277c4360
Publikováno v:
Medical Review, Vol 4, Iss 5, Pp 367-383 (2024)
COVID-19 posed a major challenge to the healthcare system and resources worldwide. The popularization of vaccines and the adoption of numerous prevention and control measures enabled the gradual end of the COVID-19 pandemic. However, successive occur
Externí odkaz:
https://doaj.org/article/59e42fcdd96f40f9a7380ccf56b96fc7
Autor:
Henry Nwankwo, James Mason, Martin Underwood, Julie Bruce, Ranjit Lall, Chen Ji, Mariam Ratna, Gordon McGregor
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Following the COVID-19 pandemic, millions of people continue to experience ongoing physical and mental health sequelae after recovery from acute infection. There is currently no specific treatment for the diverse symptoms associat
Externí odkaz:
https://doaj.org/article/0534164caa2d40428f42b6eabd0d5b09
Autor:
Fatemeh Saheb Sharif-Askari, Hawra Ali Hussain Alsayed, Narjes Saheb Sharif-Askari, Ali Al Sayed Hussain, Saleh Al-Muhsen, Rabih Halwani
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract Nirmatrelvir plus ritonavir received Emergency Use Authorization for treating mild to moderate COVID-19 in high-risk patients. Its efficacy against the Omicron variant of SARS-CoV-2 remains uncertain. This retrospective cohort study assessed
Externí odkaz:
https://doaj.org/article/72d8815603524462895e7943dff8ad85
Autor:
Richard Aubrey White, Chi Zhang, Beatriz Valcarcel Salamanca, Aslaug Angelsen, Dinastry Pramadita Zakiudin, Aristomo Andries, Saranda Kabashi, Lene Lehmann Moberg
Publikováno v:
Archives of Public Health, Vol 82, Iss 1, Pp 1-18 (2024)
Abstract Background Since 2022, Norway has employed a vaccine-only COVID-19 strategy. Primary healthcare in Norway uses International Classification of Primary Care version 2 (ICPC-2) codes. This study aims to systematically compare medically certifi
Externí odkaz:
https://doaj.org/article/a6634b5cc4dd4b9b9b666a5d64a64c14
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-14 (2024)
Abstract Background In this case series, results from daily visual exposure to intense polychromatic light of 2000 to 4000 LUX is presented. Bright light treatment is a standard procedure for treating seasonal affective disorder and prodromal Parkins
Externí odkaz:
https://doaj.org/article/c1646d173ec64994abc0bd210b945e9d